ADH1B and neoplasm: However, four tumor markers (POSTN, pSMAD2/3, CXCL14, ADH1B, FAP) that have previously been reported to predict suboptimal debulking were selected in our model, although only p-SMAD2/3 was in the same direction but with lower discriminatory performance compared to prior reports.